General Information of the Compound
| Compound ID |
CP0035063
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
7-phenyl-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]heptan-1-one
Show/Hide
|
||||||||||||||||||
| Synonyms |
681135-77-3
7-phenyl-1-(5-(pyridin-2-yl)oxazol-2-yl)heptan-1-one
7-phenyl-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]heptan-1-one
BDBM23120
CHEMBL177577
GTPL5235
ILOIOIGZFHGSMS-UHFFFAOYSA-N
KB-79672
OL-135
OL135
ORL 135
SCHEMBL1471932
ZINC3949004
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H22N2O2
|
||||||||||||||||||
| Molecular Weight |
334.419
|
||||||||||||||||||
| Canonical SMILES |
O=C(CCCCCCc1ccccc1)c1ncc(o1)-c1ccccn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H22N2O2/c24-19(14-7-2-1-4-10-17-11-5-3-6-12-17)21-23-16-20(25-21)18-13-8-9-15-22-18/h3,5-6,8-9,11-13,15-16H,1-2,4,7,10,14H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
ILOIOIGZFHGSMS-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound